MindMaze Therapeutics Holding S.A.
Market Cap
$4.38M
P/E Ratio
-42.15
EPS
$-0.01
Dividend Yield
0.00%
52-Week Range
$0.42 — $8.24
Volume
7.15K
Avg Volume
219
Beta
-0.75
P/E (TTM)
-42.15
Forward P/E
—
PEG Ratio
-0.02
P/S (TTM)
8.95
P/B (TTM)
1.11
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-0.49%
ROA (TTM)
-0.36%
ROIC
—
Gross Margin
-0.29%
Operating Margin
-2.05%
Net Margin
—
Debt/Equity
0.06
Current Ratio
4.05
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
—
EPS Growth (5Y)
—
Sales Growth (3Y)
—
Sales Growth (5Y)
—
EPS Est (This Year)
$0.00
EPS Est (Next Year)
—
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
10.39M
Float
8.18M
Free Float %
78.81%
Sector
Industrials
Industry
Specialty Business Services
Country
CH
Exchange
LSE
IPO Date
2021-01-18
Employees
31
CEO
Zach W. Henderson
Index Membership
—
Website
http://www.mindmazetherapeutics.com
MindMaze Therapeutics Holding S.A. (0QKQ.L) is a industrials company in the specialty business services industry listed on the LSE. With a market capitalization of $4.38M, a P/E ratio of -42.15, 0QKQ.L is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare 0QKQ.L against other stocks using dozens of fundamental and technical filters.
SST
System1, Inc.
$1.75
+1.74%
$17.50M
SMX
SMX (Security Matters) Public Limited Company
$8.90
-17.82%
$21.61M
ZGM
Zenta Group Company Limited Ordinary Shares
$1.75
+2.94%
$20.67M
THH
TryHard Holdings Limited
$0.44
-1.22%
$21.83M
MSGY
Masonglory Limited Ordinary Shares
$0.44
+3.19%
$6.31M
REAT.L
REACT Group PLC
$46.00
-4.17%
$10.87M
MindMaze Therapeutics Holding S.A. (0QKQ.L) has a trailing twelve-month (TTM) P/E ratio of -42.15. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, MindMaze Therapeutics Holding S.A. (0QKQ.L) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
MindMaze Therapeutics Holding S.A. (0QKQ.L) has a market capitalization of $4.38 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.